TESTOSTERONE CONTAINING PHARMACEUTICAL COMPOSITION
Application
US20260083755A1
Kind: A1
Mar 26, 2026
Assignee
NEUROCRINE UK LIMITED
Inventors
Martin Whitaker, John Porter, Richard Ross, Stewart Jones, Elizabeth Cocks
Abstract
We disclose a pharmaceutical composition adapted for oral delivery comprising native testosterone; a treatment regimen comprising administration of the composition(s); and methods and uses for the treatment of hormone related conditions such as hypogonadism in human male, female and transgender subjects.
CPC Classifications
A61K 31/568
A61K 9/48
A61K 47/10
A61K 47/44
A61P 5/26
Filing Date
2025-12-03
Application No.
19407268